opc 12759 has been researched along with rabeprazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, T; Fujiwara, S; Itoh, T; Kawakami, F; Kutsumi, H; Morita, Y; Toyonaga, T; Yoshida, M | 1 |
| Akahoshi, K; Akiho, H; Aso, A; Harada, N; Iboshi, Y; Ihara, E; Iwasa, T; Nakamura, K; Nakamura, N; Ochiai, T; Ogino, H; Takayanagi, R | 1 |
2 trial(s) available for opc 12759 and rabeprazole
| Article | Year |
|---|---|
A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine; Anti-Ulcer Agents; Disease Progression; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastritis, Atrophic; Gastroscopy; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Quinolones; Rabeprazole; Severity of Illness Index; Stomach Neoplasms; Stomach Ulcer | 2011 |
Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
Topics: Adenoma; Aged; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopic Mucosal Resection; Female; Gastric Mucosa; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Proton Pump Inhibitors; Quinolones; Rabeprazole; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2016 |